TickerFacts.

Rein Therapeutics, Inc. (RNTX): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-20. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

27.55M
As of 2025-12-31
85.77M
As of 2026-06-30
+82.4%
3-year compound annual growth
43.80M2016-12-31: 432.4K2017-12-31: 14.72M2018-12-31: 14.75M2019-12-31: 27.81M2020-12-31: 43.80M2021-12-31: 4.53M2022-12-31: 4.54M2023-12-31: 4.89M2024-12-31: 21.67M2025-12-31: 27.55M27.55M
2016-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3127.55M+27.2%2026-03-26, Balance as of period end
2024-12-3121.67M+343.5%2026-03-26, Balance as of period end
2023-12-314.89M+7.6%2025-04-07, Balance as of period end
2022-12-314.54M+0.3%2024-04-15, Balance as of period end
2021-12-314.53Mn/c2023-03-20, Balance as of period end
2020-12-3143.80M+57.5%2022-03-28, Balance as of period end
2019-12-3127.81M+88.6%2021-03-24, Balance as of period end
2018-12-3114.75M+0.2%2020-03-30, Balance as of period end
2017-12-3114.72Mn/m2019-03-29, Balance as of period end
2016-12-31432.4Kn/a2018-04-02, Balance as of period end